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Abstract: For many diseases, where a particular organ is affected, chemical by-products can be
found in the patient’s exhaled breath. Breath analysis is often done using gas chromatography and
mass spectrometry, but interpretation of results is difficult and time-consuming. We performed
characterization of patients’ exhaled breath samples by an electronic nose technique based on an
array of nanomechanical membrane sensors. Each membrane is coated with a different thin polymer
layer. By pumping the exhaled breath into a measurement chamber, volatile organic compounds
present in patients’ breath diffuse into the polymer layers and deform the membranes by changes
in surface stress. The bending of the membranes is measured piezoresistively and the signals are
converted into voltages. The sensor deflection pattern allows one to characterize the condition of the
patient. In a clinical pilot study, we investigated breath samples from head and neck cancer patients
and healthy control persons. Evaluation using principal component analysis (PCA) allowed a clear
distinction between the two groups. As head and neck cancer can be completely removed by surgery,
the breath of cured patients was investigated after surgery again and the results were similar to those
of the healthy control group, indicating that surgery was successful.
Keywords: piezoresistive membrane sensors; surface stress sensor; nanomechanical sensor; electronic
nose; breath analysis; head and neck cancer
1. Introduction
More than a century ago, medical practitioners asked patients to exhale in order to figure out
whether their breath contained specific smells possibly related to a particular disease. This old idea is
here adopted to investigate breath samples of cancer patients using a nanomechanical electronic nose
device. Specific chemical tracer substances or chemical by-products of metabolic processes are often
found in the patient’s breath for many diseases of the respiratory tract system. Conventionally, breath
samples are analyzed using gas chromatography and mass spectrometry methods, but interpretation of
results is difficult and time-consuming. Here, an electronic nose technique is presented to characterize
patients’ exhaled breath samples in a non-invasive way which allows a simpler analysis than with the
abovementioned classical standard analytical procedures.
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Cancer is a disease where cells are growing in an uncontrolled way forming a tumor, invading
and destroying adjacent healthy tissues and organs. Cancerous cells can spread to other locations in
the body via lymph or blood vessels to form metastases, the most common cause of cancer-related
death in patients with solid tumors.
Head and neck squamous cell carcinoma (HNSCC) is the fifth most important cancer type
worldwide. HNSCC is highly curable if detected early. However, second primary tumors and local
recurrences are a major challenge, the latter being the most common cause of treatment failure and
disease-related death. Early detection of HNSCC and identification of residual or recurrent disease in
treated patients allow early therapeutic intervention and may result in a survival advantage. Diagnosis
is normally performed by endoscopy and taking a biopsy of suspect lesions. We propose here a
non-invasive diagnostic technique based on detection of volatile organic compounds (VOCs) in
exhaled breath using an electronic nose technique.
Detection of head and neck cancer using patients’ exhaled breath is a well-established technique [1,2].
In cancer progression, the squamous cells of the head or neck provoke cellular oxidative stress [3],
leading to the emission of cancer-specific VOCs into the blood [4]. A part of the VOC biomarkers in
the blood are transmitted to the alveolar exhaled breath through exchange via the lung. The presence
of such VOCs (particularly straight and monomethylated alkanes and benzene derivatives) in breath
is documented by gas chromatography/mass spectrometry measurements [5,6], These types of VOCs
also occur in the breath of healthy subjects, but in a different composition ratio as in cancer patients [4].
Numerous reports on successful application of electronic noses for breath testing have been reported
in the literature for many years [7–15].
In recent years, mechanics has experienced a revival, as microfabrication technologies and
nanotechnology are applied to produce tiny structures. The development started with a novel imaging
technique named atomic force microscopy [16], which provides ultrahigh resolution of a surface on the
atomic scale. This technology is based on raster-scanning a surface with a microfabricated cantilever
beam that has a tiny tip at its free end. While keeping the distance constant between tip and surface
by controlling their interaction force, a topography map of the surface is produced, revealing details
on the atomic scale. Most frequently, a laser is used to determine the tiny deflection of the cantilever
in the nanometer range by reflecting the laser beam at the apex of the cantilever and measuring the
position with a lateral photodiode. Although the cantilever is very small, the readout still requires
tabletop-sized equipment.
A cantilever beam is an excellent force sensor for ultra-small forces in the nano-Newton range.
The high sensitivity can not only be used for atomic force microscopy, but also allows one to apply the
cantilever beam for measuring surface forces during molecular adsorption processes on the cantilever
surface, thus enabling cantilevers as chemical sensors [17].
Over the years, cantilever sensors have turned out to be very useful for detecting DNA hybridization
with single point mutation sensitivity [18], protein and antibody recognition [19], and even for assessing
patient eligibility for cancer treatment [20]. The only drawback is that the equipment for optical
cantilever deflection readout is still quite bulky. This disadvantage can be overcome by employing a
different method for deflection detection, namely the use of piezoresistor elements to determine bending.
The required readout electronics then fits in a portable box of 10 cm ˆ 10 cm ˆ 16 cm, including data
acquisition and gas handling. For detection of head and neck cancer, we take here advantage of the
bending responses of an array of piezoresistive polymer-coated membranes due to exposure to VOCs.
2. Materials and Methods
2.1. Microfabrication
Medical applications favor the routine use of a compact, small-sized, portable and non-invasive
device. A prototype was used to examine patients’ exhaled breath samples in search for VOC patterns
associated with head and neck cancer. Membrane-type surface stress sensors (MSS) have been
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first described by Yoshikawa et al. [21]. Their application for medical sensing have been reported
in by Loizeau et al. [22,23]. MSS arranged in arrays for molecular detection in gaseous phase have
been microfabricated from silicon-on-insulator substrates and structured by deep reactive ion etching.
The round membranes have a diameter of 500 µm and a thickness of 2.5 µm and are suspended by four
sensing beams with integrated p-type piezoresistors, representing a full Wheatstone bridge (Figure 1).
The p-doped piezoresistors have been fabricated using two distinct doping processes (ion diffusion
through boron silica glass and implantation). The latter method features shallow resistors, which are
very sensitive to surface stress changes.
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exposure to an individual patient’s breath samples. The polymers applied are carboxymethyl 
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Figure 2. (a) Each membrane is coated with a different polymer that responds by swelling in a 
characteristic way to surrounding molecules. Functionalization of MSS is done using inkjet spotting 
of polymer solutions in water (10 mg/mL); (b) MSS are arranged in arrays for detection of VOCs in a 
gas stream passing through the measurement chamber. The numbers on the left indicate the scale in 
millimeters. (c) Portable universal serial bus powered compact measurement device with pumping 
system for gaseous samples, signal readout and data acquisition. 
2.3. Clinical Pilot Study 
In a clinical pilot study, we investigated breath samples from head and neck cancer patients and 
healthy donors (smokers) as control persons in a double blind trial. The patient inclusion criteria 
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red), represe ting a full Wheatstone bridge. A solid supporting fram (green) holds the sensor.
2.2. Membrane Functionalization
The membranes have been coated with a thin (<1 µm) polymer layer using inkjet spotting
(Figure 2). VOCs present in the breath sample will diffuse into the polymer layer in a way characteristic
for each polymer resulting in swelling [14] and produce bending of the membrane. As eight
different polymers are used, a characteristic bending pattern of the membranes is generated on
exposure to an individual patient’s breath samples. The polymers applied are carboxymethyl
cellulose (CMC), poly-(2-ethyl-2-oxazoline) (PEO), polyethylene glycol methyl ether methacrylate
macromer (PEGMEMA), hydroxypropyl cellulose (HPC) poly(acrylic acid)-acetic acid (PAA-AA),
poly-(vinylpyridine) (PVPy), butyl rubber (PIB), and polyethylenimine (PEI).
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Figure 2. (a) Each n is coated with a diff rent polymer that responds by swell g in
a characteristi i olecules. Functionalization of MSS is done using inkjet spotting
of polymer solutions in water (10 L); (b) M S are arranged in arrays for detecti n of VOCs in
a gas strea passing through the easure ent chamber. The numbers on the left indicate the scale in
millimeters. (c) Portable universal serial bus po ered co pact easurement device with pumping
system for gaseous samples, signal readout and data acquisition.
2.3. Clinic l Pilot Study
In a clinical pilot study, we investigated breath samples from head and neck cancer patients and
healthy donors (smokers) as control persons in a double blind trial. The patient inclusion criteria were
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based on histologically confirmed carcinoma at a comparable stage. Exclusion criteria of patients to
the study population were the following:
1. Previous history of squamous cell carcinoma of the lung or upper aerodigestive tract.
2. Synchronous lesions of another histological type.
3. Heart disease (NYHA Class III or IV).
4. Serious pathology, such as infections requiring antibiotic use, uncontrolled peptic ulcers,
gastrointestinal bleeding, central nervous system disorders.
5. History of immunodeficiency or autoimmune pathologies.
6. Metastases in the central nervous system, not treated and progressing.
7. Chemotherapy, radiotherapy, immunotherapy less than 4 weeks prior to entry into the study (6
weeks for nitrosoureas).
8. Concomitant treatment with steroids and antihistamines. Topical or inhaled steroid application
is allowed.
9. Psychiatric disorders or dependencies that could prevent informed consent.
10. Kidney dysfunction with creatinine >2ˆ upper limit of normal value.
11. Diabetes.
The patients were selected from the same age groups (between 60 and 85 years old, male and
female). The clinical pilot study comprised unfortunately only a few usable patient samples. Originally
there were four healthy donors, and nine head and neck squamous cell carcinoma patients. From the
nine head and neck squamous cell carcinoma patients, there were only three who provided useable
breath samples before and after surgery. For the other six there was either only a breath sample
before surgery available or the volume of the sample was too small to allow reliable measurements
(in some cases only 0.2 L was provided, which does not allow one to reliably follow the measurement
protocol). Patients and donors were asked to breathe into a 1 liter Tedlar bag. Breath samples were
collected before surgery and after surgery, typically 2 weeks after the operation. The bags were
then stored at 4 ˝C until analysis. Each breath sample has been measured seven times, whereby the
first injection-purge cycle has been discarded to avoid influence of previous measurements.
3. Results and Discussion
Breath samples from head and neck cancer patients and healthy donors (smokers) have been
characterized by the MSS electronic nose technique. Gaseous sample from the Tedlar sample bag were
transported into the measurement chamber by pumping at a rate of 15 mL/min using micropumps
(Bartels Mikrotechnik GmbH, Dortmund, Germany). After exposure to the polymer-coated MSS sensors
for 30 s, the chamber has been purged with dry nitrogen gas also for 30 s. Several injection/purge cycles
have been performed, resulting in a chart as shown in Figure 3. Polymer-coated membranes can be
reproducibly regenerated by purging them with dry nitrogen gas.
The deflection values within an injection/purge cycle at 10, 15, 20 and 25 s after beginning of each
injection were subtracted from the value at the beginning of the injection (0 s) to reduce the influence of
possible drifts in the measurement. These four differential values obtained for each membrane sensor
were processed using principal component analysis (PCA) to be represented in a two-dimensional plot
showing one dot for each breath sample measurement, i.e., one injection-purging cycle (Figure 4).
To emphasize the distinction capability of the method, hierarchical tree analysis (unweighted
pair group method with arithmetic mean, UPGMA) was performed. In this method, the data are
analyzed by calculating the Euclidian distance between vectors consisting of data points and their
closest neighbors. Figure 5 shows the UPGMA diagram of the data. Breath measurements of NHSCC
patients before surgery are clearly different from measurements of healthy control persons and cured
NHSCC patients after surgery, demonstrating the success of surgery.
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Figure 4. Principal component analysis (PC ) plot sho ing three distinct clusters (indicated with
ellipses) that represent healthy control persons, HNSCC patients before surgery and HNSCC patients
after surgery, i.e., after removal of the tumor by operation. The points of the HNSCC patients after
surgery are at a similar location in the PCA plot as those from the healthy persons and differ clearly
from the points of the HNSCC patients before surgery, indicating that the removal of the tumor has
been successful.
Other evidence that VOC profiles in exhaled breath can be used to detect diseases has been
shown by Phillips et al. for lung and breast cancer [24]. A pilot study of analysis of air exhaled by
HNSCC patients using an array of five gold nanoparticle sensors and gas chromatography has shown
promising results [1,2]. VOCs related to diseases like diabetes mellitus and uraemia in breath were
reported to be detectable easily using polymer-coated nanomechanical cantilever arrays [25], allowing
to distinguish different VOCs.
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